Search results
Jun 14, 2021 · Dr. Burton joins Moderna after spending sixteen years with Johnson & Johnson (NYSE: JNJ). Since March 2020, he served as Chief Global Medical Affairs Officer of Janssen Pharmaceuticals where he was responsible for Janssen’s worldwide medical affairs strategy and execution.
Paul Burton is the CMO of Amgen since June 2023, with experience in biopharmaceutical industry and medical strategy. He was previously the CMO of Moderna Therapeutics and Johnson & Johnson, and a physician and researcher in cardiovascular and infectious diseases.
Jun 14, 2021 · Paul Burton, former Janssen Pharmaceuticals executive, will replace Tal Zaks as Moderna's Chief Medical Officer on July 6. He will lead the company's medical affairs strategy and execution, including the Covid vaccine development.
- Rttnews
Jun 14, 2023 · Paul Burton, M.D., Ph.D., who joined Moderna as CMO in 2021, will take on a broader role at Amgen in June 2023. He previously worked at Amgen from 2002 to 2005 and then at Johnson & Johnson for 16 years.
- Gabrielle Masson
Jun 27, 2022 · Paul Burton is a physician and executive with experience in biotechnology and pharmaceutical companies. He is currently the Chief Medical Officer at Amgen and has worked for Moderna, Janssen, and MMV.
- 500+
- Amgen
- Royal College of Surgeons of Edinburgh, UK
Jun 15, 2021 · Moderna Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that Paul Burton, M.D., Ph.D., F.A.C.C, M.R.C.S will join the Company as Chief Medical Officer, effective July 6, 2021.
Jun 15, 2023 · Paul Burton, who was CMO at Moderna for nearly two years, joins Amgen as its chief medical officer with expanded responsibilities. He will oversee global medical, regulatory affairs, patient safety, R&D strategy and operations, and report to Amgen's executive vice president of R&D.
